Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes

BACKGROUND: Anti-mitotic compounds (microtubule de-stabilizers) such as vincristine and vinblastine have been shown clinically successful in treating various cancers. However, development of drug-resistance cells limits their efficacies in clinical situations. Therefore, experiments were performed t...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Cheung, Chun Hei Antonio, Wu, Su-Ying, Lee, Tian-Ren, Chang, Chi-Yen, Wu, Jian-Sung, Hsieh, Hsing-Pang, Chang, Jang-Yang
التنسيق: Artigo
اللغة:Inglês
منشور في: Public Library of Science 2010
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933234/
https://ncbi.nlm.nih.gov/pubmed/20838440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0012564
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة